SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-030054
Filing Date
2021-07-26
Accepted
2021-07-26 21:24:52
Documents
1
Period of Report
2021-07-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5506
  Complete submission text file 0000899243-21-030054.txt   7121
Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139
Business Address
SMITH ALAN E (Reporting) CIK: 0001021037 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40629 | Film No.: 211115698
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Issuer) CIK: 0001841387 (see all company filings)

IRS No.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)